4.7 Letter

Antibiotic resistance needs global solutions

期刊

LANCET INFECTIOUS DISEASES
卷 14, 期 7, 页码 550-550

出版社

ELSEVIER SCI LTD
DOI: 10.1016/S1473-3099(14)70801-1

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study

Jeffrey D. Jenks, Juergen Prattes, Johanna Frank, Birgit Spiess, Sanjay R. Mehta, Tobias Boch, Dieter Buchheidt, Martin Hoenigl

Summary: The study demonstrated that the Aspergillus Galactomannan Lateral Flow Assay showed good diagnostic performance for invasive aspergillosis, and its performance was consistent across different patient cohorts and centers.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Do high MICs predict the outcome in invasive fusariosis?

Marcio Nucci, Jeffrey Jenks, George R. Thompson, Martin Hoenigl, Marielle Camargo dos Santos, Fabio Forghieri, Juan Carlos Rico, Valentina Bonuomo, Leyre Lopez-Soria, Cornelia Lass-Florl, Anna Candoni, Carolina Garcia-Vidal, Chiara Cattaneo, Jochem Buil, Ricardo Rabagliati, Maria Pia Roiz, Carlota Gudiol, Nicola Fracchiolla, Maria Isolina Campos-Herrero, Mario Delia, Francesca Farina, Jesus Fortun, Gianpaolo Nadali, Enric Sastre, Arnaldo L. Colombo, Elena Perez Nadales, Ana Alastruey-Izquierdo, Livio Pagano

Summary: The study did not find a clear correlation between MIC and mortality at 6 weeks in patients with invasive fusariosis, but persistent neutropenia and receipt of corticosteroids were strong predictors of 6 week mortality.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Infectious Diseases

Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

Martin Hoenigl, Jon Salmanton-Garcia, Thomas J. Walsh, Marcio Nucci, Chin Fen Neoh, Jeffrey D. Jenks, Michaela Lackner, Rosanne Sprute, Abdullah M. S. Al-Hatmi, Matteo Bassetti, Fabianne Carlesse, Tomas Freiberger, Philipp Koehler, Thomas Lehrnbecher, Anil Kumar, Juergen Prattes, Malcolm Richardson, Sanjay Revankar, Monica A. Slavin, Jannik Stemler, Birgit Spiess, Saad J. Taj-Aldeen, Adilia Warris, Patrick C. Y. Woo, Jo-Anne H. Young, Kerstin Albus, Dorothee Arenz, Valentina Arsic-Arsenijevic, Jean-Philippe Bouchara, Terrence Rohan Chinniah, Anuradha Chowdhary, G. Sybren de Hoog, George Dimopoulos, Rafael F. Duarte, Petr Hamal, Jacques F. Meis, Sayoki Mfinanga, Flavio Queiroz-Telles, Thomas F. Patterson, Galia Rahav, Thomas R. Rogers, Coleman Rotstein, Retno Wahyuningsih, Danila Seidel, Oliver A. Cornely

Summary: With an increasing number of patients requiring intensive care or being immunosuppressed, infections caused by molds other than Aspergillus spp or Mucorales are on the rise. Antifungal prophylaxis has been effective, but breakthrough infections by other rare molds are also increasing. Regional differences should be considered in providing practical clinical decision guidance.

LANCET INFECTIOUS DISEASES (2021)

Review Dermatology

Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches

Jeffrey D. Jenks, Hannah H. Nam, Martin Hoenigl

Summary: This review focuses on the epidemiology, definitions, diagnostic tests, clinical presentation, and imaging findings of invasive aspergillosis (IA) in critically ill patients in the intensive care unit, providing direction for further research.

MYCOSES (2021)

Letter Immunology

Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19)

Jeffrey D. Jenks, Saima Aslam, Lucy E. Horton, Nancy Law, Ajay Bharti, Cathy Logan, Mahnaz Taremi, Florin Vaida, Michele Ritter

CLINICAL INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology

Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, Jon Salmanton-Garcia, Johan Maertens, Marc Bourgeois, Marijke Reynders, Lynn Rutsaert, Niels Van Regenmortel, Piet Lormans, Simon Feys, Alexander Christian Reisinger, Oliver A. Cornely, Tobias Lahmer, Maricela Valerio, Laurence Delhaes, Kauser Jabeen, Joerg Steinmann, Mathilde Chamula, Matteo Bassetti, Stefan Hatzl, Riina Rautemaa-Richardson, Philipp Koehler, Katrien Lagrou, Martin Hoenigl

Summary: Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a common complication among critically ill COVID-19 patients in ICU. It is more prevalent in older patients, those receiving invasive ventilation, and those receiving tocilizumab treatment. CAPA is an independent predictor of ICU mortality.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Dermatology

Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study

Martin Hoenigl, Matthias Egger, Johannes Boyer, Eduard Schulz, Juergen Prattes, Jeffrey D. Jenks

Summary: The Aspergillus galactomannan Lateral Flow assay with digital readout from serum showed good performance for the diagnosis of probable/proven aspergillosis, with substantial agreement to serum GM. This indicates that the LFA from serum may serve as a more rapid test compared to conventional GM, particularly in settings where GM is not readily available.

MYCOSES (2021)

Article Microbiology

Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid

Matthias Egger, Samuel Penziner, Karl Dichtl, Max Gornicec, Lisa Kriegl, Robert Krause, Ethan Khong, Sanjay Mehta, Milenka Vargas, Sara Gianella, Magali Porrachia, Jeffrey D. Jenks, Iswariya Venkataraman, Martin Hoenigl

Summary: Invasive pulmonary aspergillosis (IPA) is a life-threatening disease mainly affecting immunocompromised hosts. Testing for galactomannan in serum and bronchoalveolar lavage fluid is crucial for diagnosing the disease. The novel Aspergillus-specific galactomannoprotein enzyme-linked immunosorbent assay (ELISA) demonstrates strong correlation and similar test performance to the established Platelia Aspergillus GM ELISA, making it a potential alternative test for BALF samples from patients at risk for IPA.

JOURNAL OF CLINICAL MICROBIOLOGY (2022)

Review Dermatology

Let's talk about sex characteristics-As a risk factor for invasive fungal diseases

Matthias Egger, Martin Hoenigl, George R. Thompson, Agostinho Carvalho, Jeffrey D. Jenks

Summary: Biological sex has a significant impact on the epidemiology of invasive fungal diseases, with higher proportions of females in invasive candidiasis cases and higher proportions of males in other invasive fungal infections. Further investigations are needed to understand the association between biological sex/gender and the pathogenesis of these diseases.

MYCOSES (2022)

Article Infectious Diseases

Test-of-Cure After Treatment of Pharyngeal Gonorrhea in Durham, North Carolina, 2021-2022

Jeffrey D. Jenks, Lizeth Hester, Emily Ryan, Candy Stancil, Quinn Hauser, John-Paul Zitta, Marissa Mortiboy, Malkia Rayner, Elizabeth Stevens, Savannah Carrico, Rodney Jenkins

Summary: This study analyzed the demographic and clinical characteristics, return rates for test-of-cure, and percent positivity for Neisseria gonorrhoeae in pharyngeal specimens at a local public health department in Durham, NC. Findings showed low rates of return for test-of-cure after treatment of pharyngeal gonorrhea, suggesting the need for alternative strategies to increase test-of-cure rates.

SEXUALLY TRANSMITTED DISEASES (2022)

Review Microbiology

Race and ethnicity: Risk factors for fungal infections?

Jeffrey D. Jenks, Chioma Inyang Aneke, Mohanad M. Al-Obaidi, Matthias Egger, Lorena Garcia, Tommi Gaines, Martin Hoenigl, George R. Thompson III

Summary: Racial and ethnic identities may affect the risk of acquiring infectious diseases, including fungal infections, through genetic and immunologic differences as well as underlying social determinants of health. Environmental exposures and healthcare disparities may contribute to racial and ethnic groups being more prone to certain diseases that increase the risk of fungal infections. While the reasons for the higher risk among black and African American individuals for Candida infections and cryptococcosis are unclear, social determinants of health and socioeconomic disparities may play a role. Overall, social determinants of health and immunologic mechanisms likely contribute to the risk factors for fungal infections.

PLOS PATHOGENS (2023)

Article Public, Environmental & Occupational Health

Combating COVID-19 Vaccine Inequity During the Early Stages of the COVID-19 Pandemic

Marissa Mortiboy, John-Paul Zitta, Savannah Carrico, Elizabeth Stevens, Alecia Smith, Corey Morris, Rodney Jenkins, Jeffrey D. Jenks

Summary: Throughout the COVID-19 pandemic, populations of color have experienced disproportionate impacts, including higher rates of infection, hospitalization, and mortality compared to non-Hispanic whites. These disparities are influenced by various factors, such as socioeconomic inequities, unequal access to healthcare, employment in essential or public-facing occupations, language barriers, and disparities in COVID-19 vaccination. This manuscript discusses the strategies employed by a local health department to address vaccine inequities and improve vaccination rates in historically marginalized communities, particularly the Black or African American population in Durham County, North Carolina during the early stages of the pandemic in 2021.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2023)

Article Public, Environmental & Occupational Health

Mpox Vaccination and the Role of Social Vulnerability in Durham County, North Carolina, USA

Savannah Carrico, John-Paul Zitta, Elizabeth Stevens, Rodney Jenkins, Marissa Mortiboy, Jeffrey D. Jenks

Summary: This study investigates the association between mpox vaccine administration and social vulnerability index (SVI) in Durham County, North Carolina. The results show that non-Hispanic white individuals, males, and those between the ages of 20 and 40 are overrepresented in mpox vaccine reception. Surprisingly, lacking education, health insurance, a household vehicle, and living below the poverty line are all positively associated with receiving the mpox vaccine.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2023)

Article Immunology

Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020

Thaidra Gaufin, Jill Blumenthal, Claudia Ramirez-Sanchez, Sanjay Mehta, David T. Pride, Joshua Fierer, Jeffrey D. Jenks

Summary: Shigella spp. causes a substantial number of diarrheal disease cases globally, and antimicrobial resistance is becoming a growing concern. A retrospective study conducted in San Diego, California, USA, found that Shigella flexneri was slightly more common than S. sonnei, with most cases occurring in gay or bisexual cisgender men, individuals living with HIV, homeless individuals, or methamphetamine users. The rates of antimicrobial resistance to azithromycin, fluoroquinolones, ampicillin, and trimethoprim/sulfamethoxazole were similar to national data, although the resistance rate to TMP/SMX was slightly higher.

EMERGING INFECTIOUS DISEASES (2022)

Letter Immunology

The Importance of Quantitative Results of a Lateral Flow Aspergillus Assay: The Significant Impact on Specificity Reply

Jeffrey D. Jenks, Juergen Prattes, Dieter Buchheidt, Martin Hoenigl

CLINICAL INFECTIOUS DISEASES (2021)

暂无数据